003000.KS KSC
Bukwang Pharmaceutical Co., Ltd.
1W: +4.3%
1M: -6.4%
3M: -3.9%
YTD: -6.3%
1Y: +21.4%
3Y: -41.0%
5Y: -79.4%
₩4,100.00 ($3.05)
-55.00 (-1.32%)
Weekly Expected Move ±3.7%
₩3800
₩3950
₩4100
₩4250
₩4400
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM₩215B
Revenue
+20.1% YoY
₩9B
Net Income
+6.5% YoY
₩-4,450M
Free Cash Flow
-114.7% YoY
45.0%
Gross Margin
2.5%
Op. Margin
2.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE3.0%
ROA2.1%
ROIC4.8%
Valuation
P/E67.9
P/B1.2
EV/EBITDA19.7
Leverage
Debt/Equity0.24
Current Ratio2.33
Interest Cov.11.0x
Quality Scores
Piotroski F5/9
Altman Z3.33
Beneish M-1.25